Concentration of soluble CD44 standard and soluble CD44 variant V5 in the serum of patients with malignant bone tumors.
Holzer
G
G
Department of Orthopaedics, University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, Austria. gerold.holzer@akh-wien.ac.at
Kittl
E
E
Pfandelsteiner
T
T
Trieb
K
K
Kotz
R
R
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal; D001859:Bone Neoplasms / Q000276:immunology*; D016022:Case-Control Studies; D002648:Child; D002813:Chondrosarcoma / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D018960:Hyaluronan Receptors / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012516:Osteosarcoma / Q000276:immunology; D012512:Sarcoma, Ewing / Q000276:immunology
D000911:Antibodies, Monoclonal; C113800:CD44v5 antigen; D018960:Hyaluronan Receptors